A Battle against COVID-19: Vaccine Hesitancy and Awareness with a Comparative Study between Sinopharm and AstraZeneca.
Marian S BoshraRaghda R S HusseinMarwa MohsenAhmed A ElberryAhmad Essam AltyarMahmoud TammamRania M SarhanPublished in: Vaccines (2022)
People with higher educational levels and chronic respiratory diseases represent an excellent model for accepting COVID-19 vaccination. A booster shot is recommended for people vaccinated with the Sinopharm vaccine due to a significantly higher rate of COVID-19 infection after vaccination; however, the Sinopharm vaccine shows a more acceptable safety profile.